MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 194 filers reported holding MEDICINES CO in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $895,000 | +40.3% | 18,300 | -2.7% | 0.00% | 0.0% |
Q4 2016 | $638,000 | -2.9% | 18,800 | +8.0% | 0.00% | 0.0% |
Q3 2016 | $657,000 | +43.8% | 17,400 | +27.9% | 0.00% | 0.0% |
Q2 2016 | $457,000 | -4.8% | 13,600 | -9.9% | 0.00% | 0.0% |
Q1 2016 | $480,000 | -17.7% | 15,100 | -3.2% | 0.00% | 0.0% |
Q4 2015 | $583,000 | +10.4% | 15,600 | +12.2% | 0.00% | 0.0% |
Q3 2015 | $528,000 | -78.8% | 13,900 | -84.0% | 0.00% | -75.0% |
Q2 2015 | $2,489,000 | -0.1% | 87,000 | -2.1% | 0.00% | 0.0% |
Q1 2015 | $2,491,000 | +10.9% | 88,900 | +9.5% | 0.00% | 0.0% |
Q4 2014 | $2,247,000 | +30.6% | 81,200 | +5.3% | 0.00% | +33.3% |
Q3 2014 | $1,721,000 | -23.9% | 77,100 | -0.9% | 0.00% | -25.0% |
Q2 2014 | $2,261,000 | -48.6% | 77,800 | -49.7% | 0.00% | -50.0% |
Q1 2014 | $4,399,000 | -20.2% | 154,800 | +8.5% | 0.01% | -20.0% |
Q4 2013 | $5,511,000 | +19.8% | 142,700 | +3.9% | 0.01% | +11.1% |
Q3 2013 | $4,602,000 | +22.7% | 137,300 | +12.6% | 0.01% | +12.5% |
Q2 2013 | $3,750,000 | – | 121,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,778,742 | $138,680,000 | 22.51% |
Sarissa Capital Management LP | 1,922,000 | $70,537,000 | 14.14% |
Antipodean Advisors LLC | 165,500 | $6,074,000 | 7.66% |
Boxer Capital, LLC | 1,250,000 | $45,875,000 | 5.19% |
BRIDGER MANAGEMENT, LLC | 2,604,965 | $95,602,000 | 5.18% |
Slate Path Capital LP | 1,730,000 | $63,491,000 | 4.80% |
HighVista Strategies LLC | 268,240 | $9,844,000 | 4.44% |
Camber Capital Management LP | 2,000,000 | $73,400,000 | 2.82% |
Lion Point Capital, LP | 727,205 | $26,688,000 | 2.40% |
THREE BAYS CAPITAL LP | 1,360,560 | $49,933,000 | 1.94% |